CLSI M100 S19 : 19ED 2008

Abstract
Committee Membership
Summary of Major Changes in this Document
Summary of CLSI Processes for Establishing Interpretive
Criteria and QC Ranges
CLSI References Methods vs Commercial Methods and CLSI
vs FDA Breakpoints
Subcommittee on Antimicrobial Susceptibility Testing
Mission Statement
Introduction to Table 1 and 2 for Use With M02-A10 (Disk
Diffusion) and M07-A8 (MIC Testing)
Appendix A - Screening and Confirmatory Tests for ESBLs
             in Klebsiella pneumoniae, K. Sytoca, Escherichia
             coli, and Proteus mirabilis
Appendix B - Screening Tests for Beta-Lactamase Production
             Oxacillin Resistance, mecA-Mediated Oxacillin
             Resistance Using Cefoxtin, Vancomycin
             MIC >= 8 [mu]g/mL, Inducible Clindamycin Resistance,
             and High-Level Mupirocin Resistance in
             Staphylococcus aureus Group
Appendix C - Screening Tests for Beta-Lactamase, mecA-Mediated
             Ocacillin Resistance Using Cefoxitin and Inducible
             Clindamycin Resistance in Coagulase-Negative
             staphylococci (except Staphylococcus lugdunensis)
Appendix D - Screening Tests for High-Level Aminoglycoside
             Resistance (HLAR) and Vancomycin Resistance in
             Enterococus Spp
Appendix E - Suggestions for Verification of Antimicrobial
             Susceptibility Test Results and Confirmation of
             Organism Identification
Appendix F - Quality Control Strains for Antimicobial
             Susceptibility Tests
Appendix G - Screening and Confirmatory Tests for Suspected
             Carbapenemase Production in Enterobacteriaceae
Glossary I (Part 1) - Beta-lactams: Class and Subclass
                      Designation and Generic Name
Glossary I (Part 2) - Non-Beta-lactams: Class and Subclass
                      Designation and Generic Name
Glossary II - Abbreviations/Routes of Administration/Drug Class
              for Antimicrobial Agents Listed in M100-S19
Glossary III - List of Identical Abbreviations Used for More
               Than One Antimicrobial Agents in US Diagnostic
               Products
Summary of Comments and Subcommittee Responses
The Quality Management System Approach
Related CLSI References Materials